dpp 4 glp 1 combination DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner GLP-1 analogues and DPP-4 inhibitors
Description
All-cause and cause-specific mortality in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: a nationwide registry study
Ravussin E, Smith SR, Mitchell JA, et al
While tirzepatide has demonstrated a generally favorable safety profile in clinical trials, specific considerations apply when treating patients with autoimmune thyroid disease and hypothyroidism
This can happen even if you have never had heart failure or heart problems before
It is associated with numerous short- and long-term health complications, including cardiometabolic and psychosocial consequences
